Search research articles
Contact Us
Filters
Showing results (51-60 of 93) with videos related to
Page
of 10
Sort By:
International Immunology
|
September 11, 2012
Complement receptor type 1 (CR1, CD35) is a potent inhibitor of B-cell functions in rheumatoid arthritis patients
Mariann Kremlitzka, Anna Polgár, Lívia Fülöp, et al.
Autoimmunity
|
March 23, 2002
Plasmapheresis modulates Th1/Th2 imbalance in patients with systemic lupus erythematosus according to measurement of intracytoplasmic cytokines
Pál Soltész, Magdolna Aleksza, Péter Antal-Szalmás, et al.
Journal of Immunology Research
|
December 17, 2016
Complement Receptor Type 1 Suppresses Human B Cell Functions in SLE Patients
Mariann Kremlitzka, Bernadett Mácsik-Valent, Anna Polgár, et al.
Annals of the New York Academy of Sciences
|
September 6, 2007
Anti-vitamin D, vitamin D in SLE: preliminary results
Jozélio Freire Carvalho, Miri Blank, Emese Kiss, et al.
Mediators of Inflammation
|
September 5, 2015
Systemic Autoimmune, Rheumatic Diseases and Coinciding Psoriasis: Data from a Large Single-Centre Registry and Review of the Literature
Anna Bazsó, Péter Szodoray, Ágnes Szappanos, et al.
Cell Stress & Chaperones
|
March 15, 2002
Heat shock protein 70 is a potent activator of the human complement system
Zoltán Prohászka, Mahavir Singh, Kálmán Nagy, et al.
Human Immunology
|
June 12, 2010
Measurement of interleukin-1 receptor antagonist in patients with systemic lupus erythematosus could predict renal manifestation of the disease
Boglarka Brugos, Emese Kiss, Csaba Dul, et al.
Clinical and Experimental Rheumatology
|
December 11, 2019
Glucocorticoid receptor polymorphisms in rheumatoid arthritis: results from a single centre
Anna Bazsó, Annamária Kövesdi, Rita Rásonyi, et al.
Expert Review of Clinical Immunology
|
May 19, 2010
Gene expression profiles of systemic lupus erythematosus and rheumatoid arthritis
Michael Centola, Zoltan Szekanecz, Emese Kiss, et al.
Rheumatology (Oxford, England)
|
March 5, 2011
Experiences with tumour necrosis factor-{alpha} inhibitors in patients with juvenile idiopathic arthritis: Hungarian data from the National Institute of Rheumatology and Physiotherapy Registry
Krisztina Sevcic, Ilonka Orban, Valentin Brodszky, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 93) with videos related to
Sort By:
Page
of 10
International Immunology
|
September 11, 2012
Complement receptor type 1 (CR1, CD35) is a potent inhibitor of B-cell functions in rheumatoid arthritis patients
Mariann Kremlitzka, Anna Polgár, Lívia Fülöp, et al.
Autoimmunity
|
March 23, 2002
Plasmapheresis modulates Th1/Th2 imbalance in patients with systemic lupus erythematosus according to measurement of intracytoplasmic cytokines
Pál Soltész, Magdolna Aleksza, Péter Antal-Szalmás, et al.
Journal of Immunology Research
|
December 17, 2016
Complement Receptor Type 1 Suppresses Human B Cell Functions in SLE Patients
Mariann Kremlitzka, Bernadett Mácsik-Valent, Anna Polgár, et al.
Annals of the New York Academy of Sciences
|
September 6, 2007
Anti-vitamin D, vitamin D in SLE: preliminary results
Jozélio Freire Carvalho, Miri Blank, Emese Kiss, et al.
Mediators of Inflammation
|
September 5, 2015
Systemic Autoimmune, Rheumatic Diseases and Coinciding Psoriasis: Data from a Large Single-Centre Registry and Review of the Literature
Anna Bazsó, Péter Szodoray, Ágnes Szappanos, et al.
Cell Stress & Chaperones
|
March 15, 2002
Heat shock protein 70 is a potent activator of the human complement system
Zoltán Prohászka, Mahavir Singh, Kálmán Nagy, et al.
Human Immunology
|
June 12, 2010
Measurement of interleukin-1 receptor antagonist in patients with systemic lupus erythematosus could predict renal manifestation of the disease
Boglarka Brugos, Emese Kiss, Csaba Dul, et al.
Clinical and Experimental Rheumatology
|
December 11, 2019
Glucocorticoid receptor polymorphisms in rheumatoid arthritis: results from a single centre
Anna Bazsó, Annamária Kövesdi, Rita Rásonyi, et al.
Expert Review of Clinical Immunology
|
May 19, 2010
Gene expression profiles of systemic lupus erythematosus and rheumatoid arthritis
Michael Centola, Zoltan Szekanecz, Emese Kiss, et al.
Rheumatology (Oxford, England)
|
March 5, 2011
Experiences with tumour necrosis factor-{alpha} inhibitors in patients with juvenile idiopathic arthritis: Hungarian data from the National Institute of Rheumatology and Physiotherapy Registry
Krisztina Sevcic, Ilonka Orban, Valentin Brodszky, et al.
Page
of 10